Carl Hull Named President and Chief Operating Officer of... (ect the occurrence of subsequentevents. ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Carl Hull Named President and Chief Operating Officer of Gen-Probe

Date:2/11/2008

ect the occurrence of subsequent events.

Contact:

Michael Watts

Senior director, investor relations and

corporate communications

858-410-8673

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
3. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
4. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
5. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
6. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
7. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
8. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
9. Ikaria Founding Scientist Named 2007 MacArthur Fellow
10. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
11. Abbott Named One of the Best Places to Launch a Career by BusinessWeek

Post Your Comments:

Breaking Biology Technology:Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4 BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2 BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3

[0] Quest Diagnostics Declares Quarterly Cash Dividend [0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease [0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea [0] BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes

Other Biology Technology:Lev Pharmaceuticals Invites You to Participate in its Q3'07 Earnings Results Conference Call and Webcast 2 Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results 2 Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 2 Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 3 Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 4 Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 5 Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 6

Lev Pharmaceuticals Invites You to Participate in its Q3'07 Earnings Results Conference Call and Webcast Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007

Breaking Biology News(10 mins):First phase of pan-tropical forest mapping debuting at COP15 2 First phase of pan-tropical forest mapping debuting at COP15 3 Successful stem cell therapy for treatment of eye disease 2 Hebrew University, American researchers show 'trigger' to stem cell differentiation 2 Sanford Installs New Low Dose CT Technology 49320 1 Sanford Installs New Low Dose CT Technology 49320 2 Sanford Installs New Low Dose CT Technology 49320 3 Bariatric Advantage Will Be in Attendance at the 26th Annual American Society of Metabolic and Bariatric Surgery in Dallas Texas 49316 1 Bariatric Advantage Will Be in Attendance at the 26th Annual American Society of Metabolic and Bariatric Surgery in Dallas Texas 49316 2 New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 4612 1 New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 4612 2 New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 4612 3

[0] First phase of pan-tropical forest mapping debuting at COP15 [0] Successful stem cell therapy for treatment of eye disease [0] Hebrew University, American researchers show 'trigger' to stem cell differentiation

Other Biology News:Don't go changing: New chemical keeps stem cells young 2 Living longer thanks to the 'longevity gene' 2 Beach vacations may increase future skin cancer risk in children 2

Don't go changing: New chemical keeps stem cells young Living longer thanks to the 'longevity gene'Beach vacations may increase future skin cancer risk in children

Biology Products:

CopyRight pSMART VC BamHI Cloning Kit (with electrocompetent cells) from Lucigen SuperScript Plasmid System and MAX Efficiency DH10BCompetent Cells from Invitrogen Sf21 Cells (SFM Adapted) from Invitrogen 6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer* from Molecular Probes (Invitrogen)